Evidence map›Paper›PMID 40503297›Full record

ArticleRSC advances2025

Antibiotic-conjugated antimicrobial peptides for enhanced bacterial inhibition.

Xingrao Peng, Yong Luo, Tianzhi Xu, Zihan Chen, Peiyao Chen, Cong Hu, Shuang Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xingrao PengSchool of Materials Science and Engineering, Wuhan University of Technology 122 Luoshi Road Wuhan Hubei 430070 China shuangliu@whut.edu.cn.
Yong LuoSchool of Materials Science and Engineering, Wuhan University of Technology 122 Luoshi Road Wuhan Hubei 430070 China shuangliu@whut.edu.cn.
Tianzhi XuSchool of Materials Science and Engineering, Wuhan University of Technology 122 Luoshi Road Wuhan Hubei 430070 China shuangliu@whut.edu.cn.
Zihan ChenSchool of Materials Science and Engineering, Wuhan University of Technology 122 Luoshi Road Wuhan Hubei 430070 China shuangliu@whut.edu.cn.
Peiyao ChenKey Laboratory of Fermentation Engineering (Ministry of Education), National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Hubei Key Laboratory of Industrial Microbiology, School of Life and Health Sciences, Hubei University of Technology Wuhan Hubei 430068 China.
Cong HuGuangxi Key Laboratory of Automatic Detecting Technology and Instruments, Guilin University of Electronic Technology Guilin 541004 China.
Shuang LiuSchool of Materials Science and Engineering, Wuhan University of Technology 122 Luoshi Road Wuhan Hubei 430070 China shuangliu@whut.edu.cn.ORCID https://orcid.org/0000-0001-5548-8494

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we report a pair of paenipeptin C'-based antimicrobial linear lipopeptides that significantly enhance bacterial inhibition through conjugation to antibiotics. When co-incubated with

Identifiers

PMID40503297
PMCPMC12153049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.